--- title: How to Do a PIF Most Economically? Not Every Item Requires Redoing Experiments From Scratch author: Pharmacist Hsiao-Chen lang: en canonical: https://www.pharmachen.com/pif/en/importer/most-economical-pif-path/ published: 2026-08-25 --- # How to Do a PIF Most Economically? Not Every Item Requires Redoing Experiments From Scratch **Bottom lineļ¼š** Taiwan's TFDA rules and the aligned EU scientific methods allow, under specific conditions, existing scientific data to support safety, so not every item needs costly re-testing. Whether you can take the most economical path depends on whether the assessor masters both frameworks. ## An expensive misconception Many assume a PIF means redoing all safety and toxicology tests, an astronomical cost that makes them give up. This is wrong and makes you overspend. In reality, safety support may, under specific conditions, use existing scientific data, without re-running costly animal or human tests for every item. A well-planned PIF and one forcing every item as new can differ greatly in cost. ## The trap: savings depend on who judges Judging what can be supported by existing data and what must be done requires mastering both frameworks: EU-recognized scientific assessment methods and Taiwan's specific TFDA rules. Only when they align does the judgment hold. General agents or makers, seeking the easy path, often do every item in full. Easy for them, not for your wallet. The judgment to take the most economical compliant path is what actually saves you money. ## So what you should spend on isn't money It's one feasibility judgment. Before investing in any experiment or document fees, assess what you're missing, what existing data can support, what must be done, and what the most economical path looks like. Get this right, and every dollar after is spent with confidence. Skipping it and throwing money at documents is the most expensive approach. ## FAQ ### Does a PIF require redoing experiments for every item? No. Taiwan's TFDA rules and aligned EU scientific methods allow, under specific conditions, existing scientific data to support safety, without costly re-testing for every item. ### Why can some ingredients skip redoing experiments? If an ingredient's safety has sufficient existing scientific data, or falls within coverage of existing assessment, existing data may support it under qualifying conditions, replacing unnecessary repeat testing. Case-by-case judgment still applies. ### Why is a general agent sometimes more expensive? General agents, seeking process ease, often take the most conservative approach and do every item in full. Easy for them, but you may overpay for testing that could have been saved. ### How do I know my product can pass the most economical way? It needs professional judgment mastering both EU methods and Taiwan rules. Do a feasibility assessment first to find what can be saved and what must be done. --- https://www.pharmachen.com/pif/en/importer/most-economical-pif-path/